DecisionScope is the diagnostic layer beneath qualification. It scores buyer readiness across four dimensions and prescribes the protocol that closes the gap.
Every B2B sales methodology (MEDDIC, Challenger, SPIN, Command of the Message) was built to optimize what the seller does. None of them measure whether the buyer can actually decide. That is a different category of instrument. DecisionScope is the first one built for it.
22%
22%
Win-rate lift with risk-mitigation
THE PATTERN
Three patterns. One root cause.
Demos that ghost.
Your AE walks into the call, delivers the standard pitch, and the prospect checks out by minute four. Not because the product is wrong. Because nobody diagnosed what the buyer actually needed to hear.
Win rates you can't explain.
You're generating leads. You're booking meetings. You're running the process. But your win rate sits below 20% and nobody can tell you exactly where the breakdown is. All you have are just theories.
Deals that go dark.
A deal you were sure about goes silent after the call. Two follow-ups, no reply. You thought the conversation went well. It didn't.
THE PROOF
Most sales consultants promise win rate lift. Win rate is a composite of fifteen variables. Rep skill. Pricing. ICP fit. Economic conditions. Competitor moves. Attribution dies in the noise. We measure something cleaner. Your Indecision Rate is the percent of your active open deals with at least one dimension scoring RED. We baseline it at kickoff. We check in at thirty days. We measure the outcome at day 120. The delta is yours.
The diagnostic finds the gap.
DecisionScope scores your pipeline across four dimensions. Each dimension either passes or triggers a protocol. The diagnostic is the evidence layer that tells you exactly which readiness state is incomplete and why the deal is stalling.
The protocol prescribes the fix.
Each dimension maps to a specific protocol: Urgency, Framework, Proof, or Alignment. The protocol is not generic advice. It is a prescribed intervention sequence built from your pipeline's specific evidence.
The brief makes it executable.
The 30-day implementation brief tells your team what to run, in what order, starting Monday. Week one through week four. Concrete enough to hand your sales leader without a meeting.
WHERE WE SIT
Sales methodologies have been the dominant instrument in B2B revenue for forty years. They are good at what they do: tell a rep how to advance a buyer who is already in motion. None of them measure whether the buyer is in motion in the first place. That is the gap.
QUESTION
You can run MEDDIC and DecisionScope in the same week. They are not competing instruments. The methodology tells your reps how to engage. The diagnostic tells you whether engaging will matter. One operates on the seller. The other operates on the buyer.
WHAT CHANGES
Your team gets something they've never had: a structured read on buyer readiness before the first slide loads.
Which deals are real
See which deals in your pipeline have genuine buyer readiness and which are wasting your team's calendar. Stop guessing which opportunities deserve your best rep's time.
What each buyer needs
Know what each buyer needs to see, hear, and believe before they'll move forward. Every call informed by where the buyer actually is in their decision process.
Where the process breaks
Get evidence, not opinions. The diagnostic shows exactly where in your pipeline deals lose momentum, backed by scored evidence across four measurable dimensions.
A measurable starting point
We do not promise win rate lift. Win rate is a composite of fifteen variables. We commit to the Indecision Rate, the metric DecisionScope owns cleanly. We baseline it at kickoff, check in at thirty days, and measure the outcome at day 120. The delta is the proof point.
HOW WE MEASURE
The metric we move. The metric we own.
Most sales consultants commit to win rate. Win rate takes a year to read and credits everyone in the room. We commit to something faster, cleaner, and ours.
Indecision Rate
The percent of your active open deals with at least one dimension scoring RED. We baseline it at kickoff. We check in at thirty days to make sure the protocols are landing. We measure the outcome at day 120. The delta is the proof point. This is the metric DecisionScope owns cleanly. No other consultant can claim it because no other instrument produces it.
Stalled-deal resurrection
Of deals stuck more than thirty days at intake, the percent that move forward within sixty days of protocol implementation. This is the fast-cycle proof. The deals you had written off start moving again. Your pipeline reads differently in two months.
Forecast accuracy
Indecision destroys forecast accuracy because reps cannot read buyer readiness. The four-dimension diagnostic produces a deal-level readiness read your CRM does not capture. When forecast accuracy moves materially against pre-engagement baseline, that is a board-level conversation.
No-decision loss rate
Of your closed-lost deals in a quarter, the percent lost to no-decision instead of a competitor. This is the number underneath win rate. Cleaner than win rate because it isolates indecision from pricing, ICP fit, and competitor moves. When this number falls quarter over quarter, the fix is working.
Four metrics. Three horizons. Win rate is the trailing confirmation, not the headline promise.
THE PROCESS
Three steps from uncertainty to a plan that moves deals.
Diagnose your open pipeline.
It starts free. After the four-minute Check and a short scoping call to confirm fit, I score your real open pipeline across the four dimensions, each gap named with evidence from your CRM, calls, and email. You get your Indecision Rate and a scored diagnostic report in a live Readout within five business days. No charge.
01
Prescribe the protocol per deal.
For every dimension that scores RED, I prescribe the specific protocol that closes the gap. Urgency. Framework. Proof. Alignment. Each protocol is a sequence built from your pipeline's evidence, not a generic playbook.
02
Build the fix
This is the Protocol Build, the paid, done-for-you step. The protocol sequences and assets built for your pipeline, a 30-day implementation brief for your sales leader, and two debrief sessions in weeks two and four. Priced as a fraction of one of your deals, and backed by the Indecision Reduction Guarantee.
03
THE FRAMEWORK
Every stalled deal breaks down along predictable lines. The Indecision Rate Diagnosis measures all four.
Problem Conviction
Does the buyer believe they have the problem you solve? Not awareness. Ownership. Without conviction that the status quo is unacceptable, no pitch, no presentation, and no discount will create urgency. The Urgency Protocol builds the case for change before the first real sales conversation.
Evaluation Clarity
Does the buyer know how to evaluate solutions like yours? When buyers can't evaluate clearly, they default to price comparisons or freeze entirely. The Framework Protocol gives buyers a decision framework they trust before the sales process begins.
Outcome Confidence
Does the buyer believe your solution will deliver in their specific environment? Not general confidence in the category. Confidence that your solution fits their team, their market, their constraints. The Proof Protocol bridges the gap with implementation evidence, reference architecture, and integration clarity before the deal reaches evaluation.
Organizational Readiness
Can the buying group actually move? Most sales orgs are told to align all thirteen stakeholders Forrester says exist in the average buying group. The data says otherwise. Win rates peak at four to five decisive stakeholders and decline beyond six. The Alignment Protocol navigates the committee before the deal reaches a decision point, not after it stalls. Source: Brontén, Journal of Systems Thinking, 2025.
FIT CHECK
Here's how to know if this was built for you.
Built for you if...
You've built a pipeline that looks healthy on paper, but your win rate tells a different story. More than half your losses end in 'no decision' instead of a competitor win. You suspect the breakdown happens before the conversation, not during it.
Not the right fit if...
You're pre-revenue or still searching for product-market fit. You sell through product-led growth without a sales-led process. Your primary challenge is generating leads, not converting them. Or you're looking for sales training rather than a diagnostic.
WHAT YOU RECEIVE
The free Diagnosis gives you a scored, evidence-backed read on your pipeline. The paid Protocol Build turns that read into a done-for-you fix. Here is what is in each.
Four-Dimension Diagnostic Report
Free, from your Diagnosis. A branded PDF documenting your pipeline's readiness scores across all four dimensions: Problem Conviction, Evaluation Clarity, Outcome Confidence, and Organizational Readiness each with RED/YELLOW/GREEN status per dimension, specific evidence behind each rating, and a plain-language primary diagnosis written for you and your leadership team.
01
Protocol Prescriptions
Free, from your Diagnosis. Every link that scores RED, what it's costing you, and the protocol that fixes it. The build spec, what to run and in what order, comes with the paid Protocol Build.
02
30-Day Implementation Brief
Part of the paid Protocol Build. Week by week. Week one: what to stop doing. Week two: what to run first. Week three: what to measure. Week four: what to adjust. Concrete enough to hand your sales leader and start immediately.
03
FAQ
What does this cost?
The diagnosis is free. The free Buyer Readiness Check gives you a gut read, and a free Scoping Call sets up the Indecision Rate Diagnosis on your real pipeline, also free. You pay only for the Protocol Build, the done-for-you work that resolves the gaps the Diagnosis finds. The Build is priced as a fraction of one of your own deals: a quarter for a single gap, up to half for the full chain, starting at $10,000. It is backed by the Indecision Reduction Guarantee: if your Indecision Rate hasn't dropped by the threshold in your agreement within 120 days, half your execution spend is refunded.
What is the diagnostic gap?
The gap between qualified pipeline and closed revenue that no sales methodology measures. MEDDIC, BANT, Challenger, and SPIN measure whether a deal is qualified and how the seller should engage. None of them measure whether the buyer is actually ready to decide. That gap is where 40 to 60 percent of qualified B2B pipeline disappears. DecisionScope is the diagnostic instrument built for the gap. It does not replace your methodology. It tells you whether the methodology has a chance.
How is this different from sales training?
Sales training teaches your team how to sell better. The diagnostic tells you why deals are actually stalling. Training addresses symptoms. The diagnostic identifies root causes and prescribes the specific protocol to fix them. Most companies try training first, then discover the problem was never in the pitch.
What exactly is the Indecision Rate Diagnosis?
It's the free step that scores your pipeline across four dimensions of buyer decision readiness: Problem Conviction, Evaluation Clarity, Outcome Confidence, and Organizational Readiness. The Diagnosis names which links are RED, what they're costing you, and the protocol that fixes each one.
What does the free Buyer Readiness Check involve?
Four minutes and fourteen questions, answered from your gut about your last ten deals. No call required. Your rough read shows on screen as soon as you finish.
What do I actually receive?
From the free Indecision Rate Diagnosis, delivered in a live Readout within 5 business days of your intake call: a report scored across the four dimensions with specific evidence behind each rating, the link scoring RED, what it's costing you, and the protocol that resolves it. Designed to be shown to your co-founder, VP of Sales, or board. It reads like a diagnosis, not a consulting memo. From the paid Protocol Build: the done-for-you execution of that protocol, including the implementation brief that tells your team exactly what to run and in what order, backed by the 120-day guarantee.
What size company is this for?
Companies between $10M and $100M in revenue where the pipeline looks active but win rates are flat. If your deals are dying to indecision rather than competitors, and you run a sales-led process, this is the gap DecisionScope was built to close.